MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
TRVN
Stock ticker:
PRICE
CHANGE
CAPITALIZATION

Trevena (TRVN) Ownership - Who owns Trevena?

Trevena Inc is an American biopharmaceutical company focused on developing and commercializing novel medicines for patients affected by central nervous system, or CNS, disorders... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
9.59K
P/E Ratio
N/A
Total Cash
13.46M
Projected Growth
N/A
Total Debt
37.56M
Revenue
546K
Risk (Beta)
0.26
Dividend Yield
N/A
Total Cash/Share
15.58
Total Debt/Equity
N/A
Revenue/Share
0.63 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for TRVN
A.I. Advisor
published General Information

General Information

a clinical stage biopharmaceutical company that discovers, develops and intends to commercialize therapeutics products

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A